Last reviewed · How we verify

NCT05335967

Effectiveness Evaluation of a Self-management Program for Prostate Cancer Survivors

Completed NA Last updated 3 January 2025
What this trial tests

NA trial testing Self-management program in Prostatic Neoplasms in 85 participants. Completed in 31 July 2024.

Timeline
20 May 2022
Primary endpoint
31 July 2024
31 July 2024

Quick facts

Lead sponsorNational Taipei University of Nursing and Health Sciences
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposehealth services research
Enrollment85
Start date20 May 2022
Primary completion31 July 2024
Estimated completion31 July 2024
Sites2 locations across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

National Taipei University of Nursing and Health Sciences

Who can join

Adults 20 to 80, male only, with Prostatic Neoplasms or Self-Management. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objectives: This project aims to develop a self-management program for survivors with prostate cancer experiencing urinary incontinence following radical prostatectomy and determine its effectiveness. Methods: The investigators will develop a self-management program and conduct a study on survivors with prostate cancer experiencing urinary incontinence following radical prostatectomy. And the investigators will test the effectiveness of the self-management program. After completing a pretest, participants will be randomly assigned to the experimental or control group. The self-management group will receive the self-management program for 12 weeks, whereas the information group will receive an information package on a healthy diet. Posttests will be administered 12 and 16 weeks after the pretest. The study variables will include physical symptoms and bothers, cancer-related self-efficacy, social participation, demoralization, and resilience.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Development and assessment of a self-management intervention for urinary incontinence among patients with prostate cancer: protocol for a randomized feasibility study.
    Chien CH, Liu KL, Wu CT, Chuang CK, et al · · 2023 · cited 4× · PMID 37980490 · DOI 10.1186/s12894-023-01367-7

Verify or expand the search:

Other trials of Self-management program

Trials testing the same drug.

Other recruiting trials for Prostatic Neoplasms

Currently open trials in the same condition.

Other National Taipei University of Nursing and Health Sciences trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05335967.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing